WO2009019868A1 - １０ａ、１２位架橋型１０ａ－アザライド化合物 - Google Patents

１０ａ、１２位架橋型１０ａ－アザライド化合物 Download PDF

Info

Publication number
WO2009019868A1
WO2009019868A1 PCT/JP2008/002129 JP2008002129W WO2009019868A1 WO 2009019868 A1 WO2009019868 A1 WO 2009019868A1 JP 2008002129 W JP2008002129 W JP 2008002129W WO 2009019868 A1 WO2009019868 A1 WO 2009019868A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound crosslinked
azalide compound
bacterium
erythromycin
azalide
Prior art date
Application number
PCT/JP2008/002129
Other languages
English (en)
French (fr)
Inventor
Tomohiro Sugimoto
Kanako Yamamoto
Jun Kurosaka
Naoki Sasamoto
Masato Kashimura
Tomoaki Miura
Kenichi Kanemoto
Tomohiro Ozawa
Ken Chikauchi
Eiki Shitara
Original Assignee
Taisho Pharmaceutical Co., Ltd.
Meiji Seika Kaisha, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co., Ltd., Meiji Seika Kaisha, Ltd. filed Critical Taisho Pharmaceutical Co., Ltd.
Priority to US12/671,813 priority Critical patent/US8293715B2/en
Priority to EP08790393A priority patent/EP2177526A4/en
Priority to JP2009526338A priority patent/JPWO2009019868A1/ja
Publication of WO2009019868A1 publication Critical patent/WO2009019868A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

　インフルエンザ菌又はエリスロマイシン耐性菌（例えば耐性肺炎球菌及び連鎖球菌）に対しても有効な下記式で表される１０ａ及び１２位で架橋された新規な１０ａ－アザライド化合物。
PCT/JP2008/002129 2007-08-06 2008-08-06 １０ａ、１２位架橋型１０ａ－アザライド化合物 WO2009019868A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US12/671,813 US8293715B2 (en) 2007-08-06 2008-08-06 10a-Azalide compound crosslinked at 10a- and 12-positions
EP08790393A EP2177526A4 (en) 2007-08-06 2008-08-06 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12
JP2009526338A JPWO2009019868A1 (ja) 2007-08-06 2008-08-06 １０ａ、１２位架橋型１０ａ−アザライド化合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-203769 2007-08-06
JP2007203769 2007-08-06

Publications (1)

Publication Number Publication Date
WO2009019868A1 true WO2009019868A1 (ja) 2009-02-12

Family

ID=40341109

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/002129 WO2009019868A1 (ja) 2007-08-06 2008-08-06 １０ａ、１２位架橋型１０ａ－アザライド化合物

Country Status (4)

Country Link
US (1) US8293715B2 (ja)
EP (1) EP2177526A4 (ja)
JP (1) JPWO2009019868A1 (ja)
WO (1) WO2009019868A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009139181A1 (ja) * 2008-05-15 2009-11-19 大正製薬株式会社 ４員環構造を有する１０ａ－アザライド化合物
CN110590547A (zh) * 2012-12-07 2019-12-20 开曼化学股份有限公司 前列环素衍生物的合成方法

Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54154724A (en) 1978-04-25 1979-12-06 Boots Co Ltd Novel optically active base and its manufacture
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4517359A (en) 1981-03-06 1985-05-14 Sour Pliva Farmaceutska, Kemijska Prehrambena I Kozmeticka Industrija, N.Sol.O. 11-Methyl-11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one and derivatives thereof
EP0284203A2 (en) 1987-02-24 1988-09-28 Beecham Group Plc Erythromycin derivatives, process for their preparation and their pharmaceutical use
EP0508726A1 (en) 1991-04-11 1992-10-14 Merck & Co. Inc. Novel process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
WO1993013116A1 (en) 1991-12-27 1993-07-08 Taisho Pharmaceutical Co., Ltd. 5-o-desosaminylerythronolide derivative
WO1994017088A1 (en) 1993-01-26 1994-08-04 Taisho Pharmaceutical Co., Ltd. 5-o-desosaminylerythronolide derivative
EP0680967A1 (fr) 1994-05-03 1995-11-08 Roussel-Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
WO1997042204A1 (en) 1996-05-07 1997-11-13 Abbott Laboratories 6-o-substituted erythromycins and method for making them
WO1998009978A1 (en) 1996-09-04 1998-03-12 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
WO1998018807A1 (fr) 1996-10-31 1998-05-07 Taisho Pharmaceutical Co., Ltd. Derives de l'erythromycine a
WO1998056801A1 (en) 1997-06-11 1998-12-17 Pfizer Products Inc. C-4''-substituted macrolide derivatives
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
WO1999028332A1 (en) 1997-12-01 1999-06-10 Abbott Laboratories 6-o-alkyl erythromycin b oxime
WO2000069875A1 (en) 1999-05-14 2000-11-23 Abbott Laboratories C-2 modified erythromycin derivatives
US6191118B1 (en) 1996-11-27 2001-02-20 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
WO2001077134A2 (en) 2000-03-23 2001-10-18 Abbott Laboratories Process for the preparation of 6-o-propargyl erythromycin derivatives
WO2002032919A2 (en) 2000-10-16 2002-04-25 Abbott Laboratories 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance
US6420535B1 (en) 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
JP2002530422A (ja) * 1998-11-20 2002-09-17 ファイザー・プロダクツ・インク １３員アザリド類および抗生物質としてのそれらの使用
WO2002096922A1 (en) 2001-05-30 2002-12-05 Abbott Laboratories An arylation method for the functionalization of o-allyl erythromycin derivatives
WO2003014136A1 (en) 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
WO2003014116A1 (en) 2001-08-06 2003-02-20 Bayer Corporation Pyrrolo[2.1-a]isoquinoline derivatives
WO2004078770A1 (en) 2003-03-05 2004-09-16 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using the same
WO2004101584A1 (en) 2003-05-13 2004-11-25 Glaxo Group Limited Macrolides substituted at the 3-position having antimicrobial activity
WO2005019238A1 (ja) 2003-08-22 2005-03-03 Meiji Seika Kaisha, Ltd. 新規アザライド及びアザラクタム誘導体とその製造法
WO2005030786A1 (en) 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited 3'-n-substituted-3-o-substituted erythronolide a derivatives
US20060142214A1 (en) 2004-12-07 2006-06-29 Or Yat S 3,6-bicyclolides
WO2007091393A1 (ja) 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. １０ａ－アザライド化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2077271A4 (en) * 2006-05-01 2010-09-15 Taisho Pharmaceutical Co Ltd MACROLIDE DERIVATIVE
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure

Patent Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54154724A (en) 1978-04-25 1979-12-06 Boots Co Ltd Novel optically active base and its manufacture
US4517359A (en) 1981-03-06 1985-05-14 Sour Pliva Farmaceutska, Kemijska Prehrambena I Kozmeticka Industrija, N.Sol.O. 11-Methyl-11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
EP0284203A2 (en) 1987-02-24 1988-09-28 Beecham Group Plc Erythromycin derivatives, process for their preparation and their pharmaceutical use
EP0508726A1 (en) 1991-04-11 1992-10-14 Merck & Co. Inc. Novel process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
US5523399A (en) 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
WO1993013116A1 (en) 1991-12-27 1993-07-08 Taisho Pharmaceutical Co., Ltd. 5-o-desosaminylerythronolide derivative
WO1994017088A1 (en) 1993-01-26 1994-08-04 Taisho Pharmaceutical Co., Ltd. 5-o-desosaminylerythronolide derivative
EP0680967A1 (fr) 1994-05-03 1995-11-08 Roussel-Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments
WO1997042204A1 (en) 1996-05-07 1997-11-13 Abbott Laboratories 6-o-substituted erythromycins and method for making them
WO1998009978A1 (en) 1996-09-04 1998-03-12 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
WO1998018807A1 (fr) 1996-10-31 1998-05-07 Taisho Pharmaceutical Co., Ltd. Derives de l'erythromycine a
US6191118B1 (en) 1996-11-27 2001-02-20 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
WO1998056801A1 (en) 1997-06-11 1998-12-17 Pfizer Products Inc. C-4''-substituted macrolide derivatives
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
WO1999028332A1 (en) 1997-12-01 1999-06-10 Abbott Laboratories 6-o-alkyl erythromycin b oxime
JP2002530422A (ja) * 1998-11-20 2002-09-17 ファイザー・プロダクツ・インク １３員アザリド類および抗生物質としてのそれらの使用
WO2000069875A1 (en) 1999-05-14 2000-11-23 Abbott Laboratories C-2 modified erythromycin derivatives
US6420535B1 (en) 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
WO2001077134A2 (en) 2000-03-23 2001-10-18 Abbott Laboratories Process for the preparation of 6-o-propargyl erythromycin derivatives
WO2002032919A2 (en) 2000-10-16 2002-04-25 Abbott Laboratories 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance
WO2002096922A1 (en) 2001-05-30 2002-12-05 Abbott Laboratories An arylation method for the functionalization of o-allyl erythromycin derivatives
WO2003014116A1 (en) 2001-08-06 2003-02-20 Bayer Corporation Pyrrolo[2.1-a]isoquinoline derivatives
WO2003014136A1 (en) 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
WO2004078770A1 (en) 2003-03-05 2004-09-16 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using the same
WO2004101584A1 (en) 2003-05-13 2004-11-25 Glaxo Group Limited Macrolides substituted at the 3-position having antimicrobial activity
WO2005019238A1 (ja) 2003-08-22 2005-03-03 Meiji Seika Kaisha, Ltd. 新規アザライド及びアザラクタム誘導体とその製造法
WO2005030786A1 (en) 2003-09-25 2005-04-07 Ranbaxy Laboratories Limited 3'-n-substituted-3-o-substituted erythronolide a derivatives
US20060142214A1 (en) 2004-12-07 2006-06-29 Or Yat S 3,6-bicyclolides
WO2007091393A1 (ja) 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. １０ａ－アザライド化合物

Non-Patent Citations (23)

* Cited by examiner, † Cited by third party
Title
BIOORGANIC & MEDICINAL CHEMISTRY, vol. 14, 2006, pages 3697 - 3711
JOURNAL OF AMERICAN CHEMICAL SOCIETY, vol. 94, 1972, pages 7586
JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 12, 1975, pages 1723
JOURNAL OF MEDICINAL CHEMISTRY, vol. 48, 2005, pages 224
JOURNAL OF ORGANIC CHEMISTRY, vol. 41, no. 21, 1976, pages 3419
JOURNAL OF ORGANIC CHEMISTRY, vol. 50, 1985, pages 1440
JOURNAL OF ORGANIC CHEMISTRY, vol. 68, 2003, pages 8847
JOURNAL OF ORGANIC CHEMISTRY, vol. 71, 2006, pages 6258
LA. PAQUETTE ET AL.: "Compendium of Organic Synthetic Methods", 1995, article "Encyclopedia of Reagents for Organic Synthesis"
P.G.M. WUTS, T. GREEN: "Protective Groups in Organic Syntheses(Third Edition,)", 1999
R.C. LAROCK, COMPREHENSIVE ORGANIC TRANSFORMATIONS, 1989
S.R. SANDLER ET AL.: "Organic Functional Group Preparations", 1968, ACADEMIC PRESS INC.
S.R. WAGNER ET AL.: "Synthetic Organic Chemistry", 1961, JOHN WILEY
See also references of EP2177526A4
TETRAHEDRON ASYMMETRY, vol. 7, 1996, pages 3371
TETRAHEDRON LETTERS, vol. 1, 1972, pages 29
TETRAHEDRON LETTERS, vol. 2, 1971, pages 195
TETRAHEDRON LETTERS, vol. 25, 1984, pages 1587
TETRAHEDRON LETTERS, vol. 41, 2000, pages 2659
TETRAHEDRON LETTERS, vol. 42, 2001, pages 315
TETRAHEDRON, vol. 34, 1978, pages 1651
TETRAHEDRON, vol. 36, 1980, pages 87
THE JOURNAL OF ANTIBIOTICS, vol. 43, no. 10, 1990, pages 1334

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009139181A1 (ja) * 2008-05-15 2009-11-19 大正製薬株式会社 ４員環構造を有する１０ａ－アザライド化合物
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
CN110590547A (zh) * 2012-12-07 2019-12-20 开曼化学股份有限公司 前列环素衍生物的合成方法

Also Published As

Publication number Publication date
US20110237784A1 (en) 2011-09-29
EP2177526A4 (en) 2012-08-22
JPWO2009019868A1 (ja) 2010-10-28
US8293715B2 (en) 2012-10-23
EP2177526A1 (en) 2010-04-21

Similar Documents

Publication Publication Date Title
WO2009062059A3 (en) Isomeric purinones and 1h-imidazopyridinones as pkc-theta inhibitors
WO2007073424A8 (en) Pure rocuronium bromide
WO2007057773A3 (en) Photoactive compounds
WO2010012442A3 (en) Insecticidal benzenedicarboxamide derivative
WO2008153154A1 (ja) 環状化合物、フォトレジスト基材及びフォトレジスト組成物
HK1138613A1 (en) Block-resistant, radiation-curablecoating systems based on high molecular mass, aqueous polyurethane dispersions
WO2009048101A1 (ja) アミド化合物
WO2007044873A3 (en) Sequences for detection and identification of methicillin-resistant staphylococcus aureus (mrsa) of mrej types xi to xx
WO2007127292A3 (en) Tigeycline crystalline forms and processes for preparation thereof
WO2006127941A3 (en) Amorphous cinacalcet hydrochloride and preparation thereof
WO2009130479A3 (en) Virus
WO2009056741A3 (fr) Ensemble d'un pneumatique et d'un organe souple
WO2006091848A3 (en) Isolated bis-linezolid, preparation thereof, and its use as a reference standard
AP2391A (en) High performance sewer system.
WO2010027150A3 (en) New preparation of hydroxychloroquine
WO2009042786A3 (en) Carbon transaction card
WO2008111096A3 (en) Novel prodrugs
UA94325C2 (ru) Фурнитурная система для окна, двери и т.п.
WO2010026117A3 (en) An alignment device
WO2007121987A3 (de) Handschuh mit aufblasbarer luftkammer
WO2008022014A3 (en) Multimember extended range compressible seal
WO2009019868A1 (ja) １０ａ、１２位架橋型１０ａ－アザライド化合物
WO2008146883A1 (ja) 睡眠改善剤
WO2011005667A3 (en) Fluid clutch device
WO2009022540A1 (ja) 化合物及び感放射線性組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08790393

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009526338

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008790393

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12671813

Country of ref document: US